TECX Other | TECTONIC THERAPEUTIC, INC.

TECTONIC THERAPEUTIC, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2024-05-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market.
2024-05-09: Form 10-Q; Item Shell company; As filed Yes.
2024-03-14: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market.
2023-11-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market.

Filed	Form	Item	As filed
2024-05-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2024-05-09	10-Q	Shell company	Yes
2024-03-14	10-K	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2023-11-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2023-11-09	10-Q	Emerging growth company	Yes
2023-08-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2023-08-10	10-Q	Emerging growth company	Yes
2023-05-11	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2023-05-11	10-Q	Emerging growth company	Yes
2023-03-23	10-K	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2023-03-23	10-K	Emerging growth company	Yes
2022-11-08	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2022-11-08	10-Q	Emerging growth company	Yes
2022-08-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2022-08-09	10-Q	Emerging growth company	Yes
2022-05-10	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2022-05-10	10-Q	Emerging growth company	Yes
2022-03-17	10-K	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2022-03-17	10-K	Emerging growth company	Yes
2021-11-04	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2021-11-04	10-Q	Emerging growth company	Yes
2021-08-05	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2021-08-05	10-Q	Emerging growth company	Yes
2021-05-13	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2021-05-13	10-Q	Emerging growth company	Yes
2021-03-18	10-K	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2021-03-18	10-K	Emerging growth company	Yes
2020-11-05	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2020-11-05	10-Q	Emerging growth company	Yes
2020-08-06	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · Nasdaq Global Select Market
2020-08-06	10-Q	Emerging growth company	Yes
2020-05-07	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · NASDAQ
2020-05-07	10-Q	Emerging growth company	Yes
2020-03-16	10-K	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · NASDAQ
2020-03-16	10-K	Emerging growth company	Yes
2019-11-07	10-Q	Stock registered under Section 12(b)	Common Stock, $0.0001 par value per share · AVRO · NASDAQ
2019-11-07	10-Q	Emerging growth company	Yes
2019-08-08	10-Q	Emerging growth company	Yes
2019-05-13	10-Q	Emerging growth company	Yes
2019-03-25	10-K	Emerging growth company	Yes
2018-11-13	10-Q	Emerging growth company	Yes

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
REGENXBIO Inc. (RGNX)	United States	$0.477B	-3.30
Entera Bio Ltd. (ENTX)		$0.485B
Eikon Therapeutics, Inc. (EIKN)	United States	$0.446B
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60
Autolus Therapeutics plc (AUTL)		$0.506B	-1.52
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Surrozen, Inc./DE (SRZN)	United States	$0.395B
AGENUS INC (AGEN)	United States	$0.383B	1.41